APPLICATION
ANDA218002
TYPE
ANDA
ORIGINAL APPROVAL
2024-04-05
LATEST ACTION
2024-04-05
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription
Products
TAFLUPROSTPrescription
TAFLUPROST 0.0015% · SOLUTION/DROPS · OPHTHALMIC
Approval history
2024-04-05UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.